INBX vs. TERN

Last updated Apr 1, 2026

Compare and contrast key facts about Inhibrx, Inc. (INBX) and Terns Pharmaceuticals, Inc. (TERN).

Performance

INBX vs. TERN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inhibrx, Inc. (INBX) and Terns Pharmaceuticals, Inc. (TERN). The values are adjusted to include any dividend payments, if applicable.

INBX vs. TERN - Yearly Performance Comparison

	2026 (YTD)	2025	2024
INBX Inhibrx, Inc.	-14.90%	412.99%	10.63%
TERN Terns Pharmaceuticals, Inc.	30.50%	629.24%	-17.93%

Fundamentals

EPS INBX : -$9.05 TERN : -$1.03
Total Revenue (TTM) INBX : $1.30M TERN : $0.00
Gross Profit (TTM) INBX : -$619.00K TERN : -$108.00K
EBITDA (TTM) INBX : -$127.21M TERN : -$101.49M

Returns By Period

In the year-to-date period, INBX achieves a -14.90% return, which is significantly lower than TERN's 30.50% return.

INBX

• 1D: 12.27%
• 1M: -9.31%
• YTD: -14.90%
• 6M: 99.61%
• 1Y: 380.56%
• 3Y*: —
• 5Y*: —
• 10Y*: —

TERN

• 1D: -0.30%
• 1M: 25.17%
• YTD: 30.50%
• 6M: 602.00%
• 1Y: 1,810.14%
• 3Y*: 64.52%
• 5Y*: 20.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

INBX vs. TERN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INBX

INBX Risk / Return Rank: 98
INBX Sharpe Ratio Rank: 97
INBX Sortino Ratio Rank: 98
INBX Omega Ratio Rank: 97
INBX Calmar Ratio Rank: 98
INBX Martin Ratio Rank: 98

TERN

TERN Risk / Return Rank: 100
TERN Sharpe Ratio Rank: 100
TERN Sortino Ratio Rank: 100
TERN Omega Ratio Rank: 99
TERN Calmar Ratio Rank: 100
TERN Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INBX vs. TERN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inhibrx, Inc. (INBX) and Terns Pharmaceuticals, Inc. (TERN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INBX	TERN	Difference
Sharpe ratio Return per unit of total volatility	3.14	17.29	-14.15
Sortino ratio Return per unit of downside risk	4.72	8.80	-4.08
Omega ratio Gain probability vs. loss probability	1.60	2.08	-0.48
Calmar ratio Return relative to maximum drawdown	10.01	61.87	-51.86
Martin ratio Return relative to average drawdown	28.28	153.05	-124.78
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INBX vs. TERN - Sharpe Ratio Comparison

The current INBX Sharpe Ratio is 3.14, which is lower than the TERN Sharpe Ratio of 17.29. The chart below compares the historical Sharpe Ratios of INBX and TERN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	INBX	TERN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.14	17.29	-14.15
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.22	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.40	0.23	+1.16

Correlation

The correlation between INBX and TERN is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

INBX vs. TERN - Dividend Comparison

Neither INBX nor TERN has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

INBX vs. TERN - Drawdown Comparison

The maximum INBX drawdown since its inception was -39.84%, smaller than the maximum TERN drawdown of -94.50%. Use the drawdown chart below to compare losses from any high point for INBX and TERN.

Drawdown Indicators

	INBX	TERN	Difference
Max Drawdown Largest peak-to-trough decline	-39.84%	-94.50%	+54.66%
Max Drawdown (1Y) Largest decline over 1 year	-37.56%	-27.56%	-10.00%
Max Drawdown (5Y) Largest decline over 5 years	—	-93.18%	—
Current Drawdown Current decline from peak	-28.10%	-0.85%	-27.25%
Average Drawdown Average peak-to-trough decline	-16.89%	-67.45%	+50.56%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.30%	11.14%	+2.16%

Volatility

INBX vs. TERN - Volatility Comparison

Inhibrx, Inc. (INBX) has a higher volatility of 23.48% compared to Terns Pharmaceuticals, Inc. (TERN) at 11.57%. This indicates that INBX's price experiences larger fluctuations and is considered to be riskier than TERN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INBX	TERN	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.48%	11.57%	+11.91%
Volatility (6M) Calculated over the trailing 6-month period	86.97%	75.90%	+11.07%
Volatility (1Y) Calculated over the trailing 1-year period	122.02%	106.22%	+15.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	98.22%	95.73%	+2.49%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.22%	97.22%	+1.00%

Financials